Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients

Nicoletta Colombo, James L. Speyer, Michael Green, Renzo Canetta, Uziel Beller, James C. Wernz, Marleen Meyers, Tova Widman, Ronald H. Blum, Martine Piccart, Franco M. Muggia, E. Mark Beckman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds